Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial. VAN Bussel MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al. Anticancer Res 2025;45:3137-3147.

Read + Share

Amedeo Smart

Independent Medical Education

VAN Bussel MTJ, Bravenboer N, Essen HV, Snaebjornsson P, et al. Bone Toxicity Case Report Combining Encorafenib, Cetuximab and WNT974 in a Phase I Trial. Anticancer Res 2025;45:3137-3147.
PMID: 40578933